Showing results (611-620 of 6,664) with videos related to

Sort By:
Pageof 667
Annals of Hematology|November 22, 1997
Myelofibrosis and idiopathic thrombocytopenic purpuraM A Seelen, P H de Meijer, E F Posthuma, et al.
Annals of Hematology|August 25, 2025
Outcomes of primary CNS lymphoma treated with combined immunochemotherapy with whole-brain radiotherapyYa Hwee Tan, Ryan Mao Heng Lim, Jing Yuan Tan, et al.
Annals of Hematology|July 9, 2015
The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantationYu-Qian Sun, Gan-Lin He, Ying-Jun Chang, et al.
Annals of Hematology|April 28, 2015
Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trialJana Schweitzer, Martin Zimmermann, Mareike Rasche, et al.
Annals of Hematology|April 23, 2015
MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantationCiprian Tomuleasa, Shigeo Fuji, Andrei Cucuianu, et al.
Annals of Hematology|April 24, 2015
Neurological complications of beta-thalassemiaP Nemtsas, M Arnaoutoglou, V Perifanis, et al.
Annals of Hematology|August 30, 2025
Comparative efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia treatment: a meta-analysis of clinical trials and Real-World outcomesAntonio Sanz-Solas, Miriam Saiz-Rodríguez, Sara Calvo Simal, et al.
Annals of Hematology|September 2, 2025
Prognostic factors and effect modifiers in patients with relapsed or refractory follicular lymphoma who failed at least two lines of therapy: a systematic literature and expert clinical reviewPau Abrisqueta, Ana Jiménez-Ubieto, Ángel Serna, et al.
Annals of Hematology|September 2, 2025
Follicular lymphoma or diffuse large B-cell lymphoma: a population based analysis of epidemiological and health economic aspects in GermanyKarin Berger, Bernhard Moertl, Michael von Bergwelt-Baildon, et al.
Annals of Hematology|July 30, 2016
Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experienceMervat M Mattar, Mohammed Abdel Kader Morad, Noha M El Husseiny, et al.
Pageof 667